These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 28224273)
1. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome. Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273 [TBL] [Abstract][Full Text] [Related]
2. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia. Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression. Jang SJ; Choi IS; Park G; Moon DS; Choi JS; Nam MH; Yoon SY; Choi CH; Kang SH Leuk Res; 2016 Aug; 47():172-7. PubMed ID: 27379838 [TBL] [Abstract][Full Text] [Related]
4. [Expression of miR-550a-5p in Myelodysplastic Syndrome and Its Prediction of Target Genes]. Huang Y; Wen J; Li HY; Zhang XP; Deng DH; Cheng P; Peng ZG; Zhao WH; Luo J; Long Y; Liu ZF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1476-1483. PubMed ID: 27784378 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-144 inhibits proliferation and promotes the apoptosis of myelodysplastic syndrome cells through the activation of the AKAP12-dependent ERK1/2 signaling pathway. Qian W; Jin F; Zhao Y; Chen Y; Ge L; Liu L; Yang M Cell Signal; 2020 Apr; 68():109493. PubMed ID: 31809872 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia. Kurotaki H; Tsushima Y; Nagai K; Yagihashi S Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673 [TBL] [Abstract][Full Text] [Related]
7. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome. Dostalova Merkerova M; Krejcik Z; Votavova H; Belickova M; Vasikova A; Cermak J Eur J Hum Genet; 2011 Mar; 19(3):313-9. PubMed ID: 21150891 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes. Choi JS; Nam MH; Yoon SY; Kang SH Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751 [TBL] [Abstract][Full Text] [Related]
9. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes. Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221 [TBL] [Abstract][Full Text] [Related]
10. Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Pons A; Nomdedeu B; Navarro A; Gaya A; Gel B; Diaz T; Valera S; Rozman M; Belkaid M; Montserrat E; Monzo M Leuk Lymphoma; 2009 Nov; 50(11):1854-9. PubMed ID: 19883312 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of microRNA-597 in myelodysplastic syndromes induces apoptosis through FOSL2 inhibition. Kang SH; Kim HB; Choi JS Eur J Haematol; 2022 Dec; 109(6):680-685. PubMed ID: 36018564 [TBL] [Abstract][Full Text] [Related]
12. Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes. Xu F; Zhu Y; He Q; Wu LY; Zhang Z; Shi WH; Liu L; Chang CK; Li X Sci Rep; 2016 Aug; 6():32232. PubMed ID: 27571714 [TBL] [Abstract][Full Text] [Related]
13. miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes. Kuang X; Wei C; Zhang T; Yang Z; Chi J; Wang L Int J Oncol; 2016 Nov; 49(5):1921-1930. PubMed ID: 27633496 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia. Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417 [TBL] [Abstract][Full Text] [Related]
15. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target. Zhang S; Zhang Q; Shi G; Yin J Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958 [TBL] [Abstract][Full Text] [Related]
16. Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes. Kuang X; Chi J; Wang L Hematology; 2016 Dec; 21(10):593-602. PubMed ID: 27357100 [TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome. Choi Y; Hur EH; Moon JH; Goo BK; Choi DR; Lee JH Korean J Intern Med; 2019 Mar; 34(2):390-400. PubMed ID: 29132200 [TBL] [Abstract][Full Text] [Related]
18. [Expression and Function of miR-99a-5p in Bone Marrow of Patients with MDS]. LE Y; Zhang XP; Xiong YQ; Li HY; Zhao WH; Long Y; Luo J; Cheng P; Liu ZF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):134-140. PubMed ID: 30738460 [TBL] [Abstract][Full Text] [Related]
19. Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia. Kirimura S; Kurata M; Nakagawa Y; Onishi I; Abe-Suzuki S; Abe S; Yamamoto K; Kitagawa M Pathology; 2016 Apr; 48(3):233-41. PubMed ID: 27020498 [TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations. Aslan D; Garde C; Nygaard MK; Helbo AS; Dimopoulos K; Hansen JW; Severinsen MT; Treppendahl MB; Sjø LD; Grønbæk K; Kristensen LS Oncotarget; 2016 Mar; 7(9):9951-63. PubMed ID: 26848861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]